AchillesMedia Coverage

BioWorld – Achilles’ I-O approach draws $120M in series B

04/09/2019
Read More +

Endpoints – RA Capital-backed cell therapy player in the neoantigen game grabs a $121M megaround to fund first human studies

03/09/2019
Read More +

Scrip – Interview: Achilles Advances Armed With £100m

03/09/2019
Read More +

BioCentury – Achilles Adds £100m To Move Neoantigen T Cell Therapy Into The Clinic

03/09/2019
Read More +

Wall Street Journal Pro Venture Capital – Achilles Therapeutics Eyes T-Cell Therapy for Solid Cancers With New Funding

03/09/2019
Read More +

Financial Times – UK biotech secures £100m funding for lung cancer trials

03/09/2019
Read More +

BioCentury – Achilles’ Truncal Neoantigens

21/01/2019
Read More +